← All companies

RANI

Rani Therapeutics Holdings, Inc.

RANI Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.83

+0.01 +0.61%

Key statistics

from XBRL data in SEC filings

Market cap

$148M

Revenue (TTM)

$3.17M

Net income (TTM)

-$29.4M

EPS (TTM)

$-0.27

P/E ratio

—

Dividend yield

—

Free cash flow

-$18.8M

Cash

$9.64M

Total assets

$51.9M

Gross margin

—

52-week range

$0.44 – $3.87

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Aug 4, 2026 8-K Director or officer change Jun 30, 2026 8-K Shareholder vote results May 29, 2026 8-K Other events May 27, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release); Delisting notice or listing-rule failure; Director or officer change May 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Terminated a material agreement; Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jan 2, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Director or officer change; Other events Oct 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Oct 17, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Other events Jul 16, 2025 8-K Delisting notice or listing-rule failure Jun 26, 2025 8-K Shareholder vote results May 29, 2025 8-K Entered a material agreement; Unregistered sale of equity May 20, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Delisting notice or listing-rule failure May 6, 2025 8-K Director or officer change Apr 30, 2025 8-K Changed accountants Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Other events Oct 16, 2024 8-K Changed accountants Sep 11, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Aug 6, 2024 8-K Other events Jul 23, 2024 8-K Regulation FD disclosure Jul 12, 2024 8-K Entered a material agreement; Other events Jun 24, 2024 8-K Shareholder vote results May 30, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release) May 6, 2024 10-K Fiscal year ended 2023-12-31 Mar 20, 2024 8-K Results of operations (earnings release) Mar 20, 2024